Molecular Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-03-01 ms212294021819060

审稿速度:1.0 | 投稿命中率:50.0
经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？

112 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-26 1811e984f8m

偏重的研究方向：肿瘤
经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。

35 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-24 Sygar

公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。

25 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-24 目标cancer discovery

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的

68 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-28 ms7000000719951706

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤微环境;外泌体;CAF
经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。

23 0

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-26 ms5000000148289639

审稿速度:4.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;外泌体
经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。

79 0

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-26 1235b519m83暂无昵称

已经有大三甲教学医院不给报销，不给奖励了。

40 0

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-25 sosolou

不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创

33 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-25 ms5000000148289639

审稿速度:4.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;CAF
经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1198227, encodeId=2e3c119822ea3, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：大家都在说灌水，看看advanced science，science advances和nc，号称最容易的三大子刊，这种收费高，国人占比高的子刊，国内课题组几乎人手一篇，是不都应该重点关注？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b021994967, createdName=ms212294021819060, createdTime=Tue Mar 01 00:34:15 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197474, encodeId=3f30119e474f1, content=偏重的研究方向：肿瘤 经验分享：molecular cancer杂志近年来尤其热门，深受国人喜爱。但一个杂志受广泛认可需要时间的沉淀，除了坚持发表高质量的论文外，还需要正确对待过去。许多pubpeer等上被揭露的发表在该杂志上的文章，不仅没有撤稿，而且连个订正都没有。在这点是，JECCR杂志就做的相对好点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Feb 26 13:02:50 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197010, encodeId=df95119e010d2, content=公众号发的网站不是中信所官网，是河北中医学院，而且现在进去河北中医学院也已经找不到这个新闻了。中信所官网也找不到正式发布的文件。口碑自在心中，立场跟利益不同和其他人辩论也没用。这个杂志不值得吹捧，但是无脑黑也不符合一个真正科研人的素养，凡事进入了二极管的非黑即白一刀切是最省事的，而辩证看待具体的每一篇文章反而是最花时间的。科研人做科研恰恰需要辩证思考。无论如何，如果因为一个没有明确出处的公告而借机拱火，也是很不妥的行为。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eab103686, createdName=Sygar, createdTime=Thu Feb 24 21:26:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196797, encodeId=46ae1196e9713, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：molecular cancer 哪怕if37+ 依然上了中信所的预警期刊哈哈哈哈普天同庆喜大普奔大佬们的眼睛是雪亮的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1b72231756, createdName=目标cancer discovery, createdTime=Thu Feb 24 13:18:20 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198111, encodeId=420c1198111e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境;外泌体;CAF 经验分享：修了一轮被Cancer Discovery拒稿。老板非要投这个杂志。目前审稿中。希望尽快发表吧。着急毕业找工作。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ddc96527955, createdName=ms7000000719951706, createdTime=Mon Feb 28 18:41:23 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197566, encodeId=c228119e56629, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;外泌体 经验分享：祸兮福所倚。这回中信所莫须有的黑名单事件，也算是给Molecular Cancer敲响警钟吧。希望主编和编辑团队意识到存在的问题，走上良性循环的道路。毕竟不少杰青大佬对这个杂志过去的印象还是不错的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Sat Feb 26 20:14:24 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197551, encodeId=dcf5119e55166, content=已经有大三甲教学医院不给报销，不给奖励了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c372403063, createdName=1235b519m83暂无昵称, createdTime=Sat Feb 26 18:43:20 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197083, encodeId=5de2119e08316, content=不是黑国人的工作，但是一旦一个期刊国人文章超过70%，基本离黑不远。国人最大特点是仿，不是创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPHdl9B6lyiaqRic84tTawZUGjGSDp9ndL6knmHianLnPhV8C4wA8x0Ybwfe9g4A3DkbkiaMJb9n0FXw/132, createdBy=906052207, createdName=sosolou, createdTime=Fri Feb 25 05:01:31 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197086, encodeId=f79d119e086ef, content=审稿速度:4.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;CAF 经验分享：https://mp.weixin.qq.com/s/_C3Ub8gfo5ZiLwqbtwJViw 第一次听说中信所, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1285504297, createdName=ms5000000148289639, createdTime=Fri Feb 25 06:23:34 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197170, encodeId=2dcc119e1701b, content=中信所文件查不到了啊，为啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cb8c1623263, createdName=paperbear, createdTime=Fri Feb 25 11:03:42 CST 2022, time=2022-02-25, status=1, ipAttribution=)]

2022-02-25 paperbear

中信所文件查不到了啊，为啥

68 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务